September 22, 2025 - Since announcing in 2022 a new organizational structure and operational model that would affect up to 8,000 jobs, Novartis has laid off 2,186 employees, based on BioSpace tallies.

March 10, 2025 - The most recent cuts followed two other rounds of layoffs at Atara — one that shrunk the headcount by 25% last year and a 20% cut in 2022. And even cell and gene therapy developers that have won approvals have faced commercialization challenges ...

September 19, 2022 - Pharma · By Fraiser Kansteiner ... from the Biogen, Teva and Novartis playbooks, AbbVie and Bristol Myers Squibb are slimming down to the tune of 360 staffers on the West Coast....

June 17, 2024 - News website Fierce Biotech has been tracking industry layoffs since 2022, recording 187 total layoffs among biotech companies last year, up from 119 in 2022.

July 11, 2024 - Nearly two dozen life sciences ... jobs hit just 13% of that target in 2024. Ten awardees had reported layoffs last year, including Charles River Laboratories and Moderna....

June 10, 2024 - Pharma staffing cuts comprise half of the industry’s overall layoffs, while reductions at biotechs and other life sciences companies make up for the rest, Ural said. However, pharma and biotech cuts have different drivers.

October 9, 2025 - Since announcing its new organizational structure and operational model in 2022, Switzerland-based Novartis’ layoffs of 2,186 employees, some of which aren’t effective until next year, include 1,012 people at its U.S. headquarters in East ...

September 6, 2024 - Subscribe to PharmaVoice for important stories, insights & perspectives · Despite FDA ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market · Biopharma layoffs rise as drugmakers tighten belts and reorganize

September 12, 2023 - More than 115 biotech companies have announced layoffs this year, on track to easily surpass 2022’s numbers. While this is not a new trend, the current trajectory is concerning, as it portends more difficult times ahead for the pharmaceutical ...

4 days ago - CSL Vifor will part ways with 55 employees, according to a Pennsylvania Worker Adjustment and Retraining Notification (WARN) Act notice. The layoffs will take effect on Dec. 1. The affected employees belong to Vifor Pharma, which in December ...

In 2022, over 100 biopharma companies had announced workforce reductions. That number has doubled in 2023. And the year has not ended as yet. In Q1 2023, the number of companies that had announced layoffs surpassed 50 and included companies ...

November 16, 2022 - Getty Images · Third quarter earning ... drugmakers. Through Wednesday, Tricida, Freeline Therapeutics, Harpoon Therapeutics, Adamis Pharmaceuticals, Neoleukin Therapeutics and NexImmune have all announced workforce ...

December 4, 2025 - The layoffs will occur in three phases: the first between May 16 and May 30, the second from June through July 7 and the final round is slated for “sometime in 2026,” per the notice.

3 weeks ago - May 8 - Teva Pharmaceuticals: As part of a new bid to save roughly $700 million by 2027, Teva will lay off around 8% of its staff over the same time frame. Story · May 8 - IGM Biosciences: Sanofi's termination of its 2022 collab with IGM Biosciences was the final nail in the coffin for the biotech’s research, given that it represented the last program in the company's pipeline.

August 26, 2025 - Before disclosing the 100-person layoff round, Pfizer had just vacated a 61,000-square-foot office building at the Bothell campus, according to a Puget Sound Business Journal report in July.

July 12, 2024 - The layoffs are part of a global restructuring initiative that began in 2022. The plan could affect up to 8,000 worldwide, according to Swiss news source Tages-Anzeiger. In an initiative dubbed “Project Energize,” over-the-counter ...

November 26, 2024 - Throughout Novartis’ multiyear ... Aside from the decision tied to Aimovig in 2021, Novartis also laid off a little over 100 and nearly 300 East Hanover staffers in 2023 and 2022, ......

September 3, 2025 - The job reductions will affect Novartis’ U.S. medical affairs organization, a company spokesperson told Fierce Pharma. While “evaluating opportunities to enhance processes, increase efficiencies, and ensure we are investing our time and resources into the areas where we can have the greatest impact,” the company is making some changes that result in “a variety of roles being eliminated, modified and created,” the spokesperson said. The latest layoffs follow another major personnel shake-up that affected 426 employees at Novartis’ U.S.

March 31, 2025 - One key driver of these recent layoffs is economic pressure from government policies. The Inflation Reduction Act (IRA), passed in 2022, has particularly impacted high-cost specialty drugs. As companies reassess the IRA’s effects on their portfolios, they are making adjustments to protect margins.

December 1, 2025 - Adding to a growing wave of workforce reductions across the pharmaceutical industry, Fate Therapeutics, Generation Bio, and ORIC Pharmaceuticals are the latest companies to announce significant layoffs this quarter.